These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 3668860

  • 1. Antiarrhythmic activity of two quinidine metabolites in experimental reperfusion arrhythmia: relative potency and pharmacodynamic interaction with the parent drug.
    Vozeh S, Oti-Amoako K, Uematsu T, Follath F.
    J Pharmacol Exp Ther; 1987 Oct; 243(1):297-301. PubMed ID: 3668860
    [Abstract] [Full Text] [Related]

  • 2. Relative electrophysiological potencies of quinidine, 3-OH quinidine and quinidine-N-oxide in guinea-pig heart.
    Uematsu T, Sato R, Vozeh S, Follath F, Nakashima M.
    Arch Int Pharmacodyn Ther; 1989 Oct; 297():29-38. PubMed ID: 2730239
    [Abstract] [Full Text] [Related]

  • 3. Dose-dependent kinetics of quinidine in the perfused rat liver preparation. Kinetics of formation of active metabolites.
    Yu VC, de Lamirande E, Horning MG, Pang KS.
    Drug Metab Dispos; 1982 Oct; 10(6):568-72. PubMed ID: 6130901
    [Abstract] [Full Text] [Related]

  • 4. Comparative in vitro electrophysiology of quinidine, its major metabolites and dihydroquinidine.
    Thompson KA, Blair IA, Woosley RL, Roden DM.
    J Pharmacol Exp Ther; 1987 Apr; 241(1):84-90. PubMed ID: 3572799
    [Abstract] [Full Text] [Related]

  • 5. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P, Tegelkamp R, Osada N, Schimpf R, Wolpert C, Breithardt G, Borggrefe M, Eckardt L.
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [Abstract] [Full Text] [Related]

  • 6. Greater quinidine-induced QTc interval prolongation in women.
    Benton RE, Sale M, Flockhart DA, Woosley RL.
    Clin Pharmacol Ther; 2000 Apr; 67(4):413-8. PubMed ID: 10801251
    [Abstract] [Full Text] [Related]

  • 7. Cardiac effects of quinidine on guinea-pig isolated perfused hearts after in vivo quinidine pretreatment.
    Yang Q, Padrini R, Piovan D, Ferrari M.
    Br J Pharmacol; 1997 Sep; 122(1):7-12. PubMed ID: 9298522
    [Abstract] [Full Text] [Related]

  • 8. Kinetics of microsomal metabolism of quinidine in rats.
    Rakhit A, Mico B.
    Res Commun Chem Pathol Pharmacol; 1985 Jul; 49(1):109-24. PubMed ID: 4035074
    [Abstract] [Full Text] [Related]

  • 9. Interaction of drug metabolites with the class I antiarrhythmic drug receptor on rat cardiac myocytes.
    Sheldon R, Thakore E, Wilson L, Duff H.
    J Pharmacol Exp Ther; 1994 May; 269(2):477-81. PubMed ID: 8182514
    [Abstract] [Full Text] [Related]

  • 10. Compared efficacy of quinidine, GABA and N-trimethyl GABA upon a model of ventricular automaticity.
    Serrano JS, Hernández J, Miñaño J.
    Methods Find Exp Clin Pharmacol; 1983 May; 5(4):251-4. PubMed ID: 6888087
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics and pharmacodynamics of quinidine and its metabolite, quinidine-N-oxide, in beagle dogs.
    Rakhit A, Guentert TW, Holford NH, Verhoeven J, Riegelman S.
    Eur J Drug Metab Pharmacokinet; 1984 May; 9(4):315-24. PubMed ID: 6532805
    [Abstract] [Full Text] [Related]

  • 12. Antiarrhythmic activity of the hydrochloride of 1-methoxymethyl-2-(1-perhydroazepinyl)ethyl ester of 2-(n)-pentyloxycarbanilic acid.
    Gibala P, Sotníková R, Knezl V, Drímal J.
    Arzneimittelforschung; 1987 Feb; 37(2):149-52. PubMed ID: 3580018
    [Abstract] [Full Text] [Related]

  • 13. Total and unbound concentrations of quinidine and 3-hydroxyquinidine at steady state.
    Wooding-Scott RA, Visco J, Slaughter RL.
    Am Heart J; 1987 Feb; 113(2 Pt 1):302-6. PubMed ID: 3812182
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antiarrhythmic profile and endothelial action of novel decahydroquinoline derivatives.
    Kozlovski VI, Vdovichenko VP, Chlopicki S, Malchik SS, Praliyev KD, Zcilkibayev OT.
    Pol J Pharmacol; 2004 Feb; 56(6):767-74. PubMed ID: 15662089
    [Abstract] [Full Text] [Related]

  • 17. A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol.
    Schmid JR, Hanna C.
    J Pharmacol Exp Ther; 1967 May; 156(2):331-8. PubMed ID: 4381702
    [No Abstract] [Full Text] [Related]

  • 18. Albumin decreases myocardial permeability of unbound quinidine in perfused rat heart.
    Morgan DJ, Huang JL.
    J Pharmacol Exp Ther; 1994 Jan; 268(1):283-90. PubMed ID: 8301569
    [Abstract] [Full Text] [Related]

  • 19. Block of NA+ and K+ currents in rat ventricular myocytes by quinacainol and quinidine.
    Pugsley MK, Walker MJ, Saint DA.
    Clin Exp Pharmacol Physiol; 2005 Jan; 32(1-2):60-5. PubMed ID: 15730436
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.